HIGH RISK HEMATOLOGICAL MALIGNANCY

Clinical trials for HIGH RISK HEMATOLOGICAL MALIGNANCY explained in plain language.

Never miss a new study

Get alerted when new HIGH RISK HEMATOLOGICAL MALIGNANCY trials appear

Sign up with your email to follow new studies for HIGH RISK HEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Breakthrough cord blood treatment shows promise for tough blood cancers

Disease control Completed

This study tested a new method to improve cord blood transplants for patients with high-risk leukemia or myelodysplasia who lack a perfect donor match. Researchers used a molecule called UM171 to expand the number of stem cells in cord blood before transplant, aiming to make the …

Matched conditions: HIGH RISK HEMATOLOGICAL MALIGNANCY

Phase: PHASE2 • Sponsor: ExCellThera inc. • Aim: Disease control

Last updated Apr 02, 2026 14:58 UTC

HIGH RISK HEMATOLOGICAL MALIGNANCY

Get alerted when new HIGH RISK HEMATOLOGICAL MALIGNANCY trials appear

Breakthrough cord blood treatment shows promise for tough blood cancers